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Abstract 
Retroviral Gag protein plays a critical role during the late stage of virus budding and 
possesses a so-called L-domain containing PT/SAP, PPxY, YxxL or FPIV motifs that 
are critical for efficient budding. Mason-Pfizer monkey virus (M-PMV) contains PSAP, 
PPPY, and YADL sequences in Gag. This study was performed to investigate the roles 
of these three L-domain-like sequences in virus replication using three different cell 
lines, 293T, COS-7, and HeLa cells. It was found that the PPxY motif plays an essential 
role in progeny virus production as a major L-domain in all three cell lines. The PSAP 
sequence was shown to function as an additional L-domain in HeLa cells and to 
promote efficient release of M-PMV; however, this sequence was dispensable for 
M-PMV production in 293T and COS-7 cells, suggesting that the role of the PSAP 
motif as an L-domain in M-PMV budding is cell type-dependent. Viruses possessing 
multiple L-domains appear to change the L-domain usage to replicate in various cells. 
On the other hand, the YADL motif was required for M-PMV production as a transport 
signal of Gag to the plasma membrane, but not as an L-domain. 
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Introduction 
Retroviral Gag proteins play critical roles during the late stage of virus budding and, 
when expressed alone in cells, they are released in the form of virus-like particles. The 
Gag protein possesses a so-called L-domain containing PT/SAP, PPxY, YPxL or FPIV, 
which are motifs critical for efficient viral budding (1-8). Human immunodeficiency 
virus type 1 (HIV-1) possesses the PTAP motif as the L-domain, Whereas the core 
element of the L-domain of Rous sarcoma virus (RSV) is the PPxY sequence. A third 
L-domain motif, YxxL (or YPxL), has been identified in equine infectious anemia virus 
(EIAV) (6). FPIV and FPVI are the L-domains identified in the matrix (M) protein of 
human parainfluenza virus type 5 (hPIV-5) and mumps virus, respectively (9, 10). Some 
retroviruses, including Mason-Pfizer monkey virus (M-PMV), human T-cell leukemia 
virus type 1 (HTLV-1), and murine leukemia virus (MuLV), contain both the PPxY and 
the PT/SAP sequences within their Gag polyproteins. The PT/STAP motif reportedly 
interacts with the Tsg101 subunit of ESCRT-I, a ubiquitin-conjugating E2 enzyme 
variant (UEV), whereas the PPxY motif interacts with Nedd4-like ubiquitin ligases 
(11-15). The cellular factor that interacts with the YxxL motif has been shown to be 
AIP1/Alix (16-20). It has been reported that hPIV-5 and mumps virus, which contain the 
FPIV or FPVI sequence as the L-domain, respectively, utilize the ESCRT machinery in 
virus budding, however, the cellular factors that interact with these L-domains have not 
been identified (9, 10).  
M-PMV belongs to the genus β-retrovirus and has type-D morphology. Previously, 
we showed that the PPPY sequence within the pp24/16 region of M-PMV Gag plays a 
critical role in virus budding as a viral L-domain and that Nedd4-like ubiquitin ligase 
BUL1 interacts with this PPPY sequence and regulates virus budding (7, 14). In 
addition, Gottwein et al. reported that the PSAP sequence in the pp24/16 region also 
functions as an additional L-domain in HeLaP4 cells, and promotes the efficient release 
of M-PMV (21). Here, we found the YxxL sequence, which has been identified as the 
third L-domain motif in the Gag proteins of EIAV and HIV-1, in p10 (Matrix) protein of 
M-PMV (6, 20). No viruses possessing three L-domains have been reported previously. 
Therefore, to examine whether this YxxL sequence functions as an L-domain and 
how these multiple L-domains regulate M-PMV budding, we investigated the roles of 
these putative L-domains of M-PMV in three different cell lines. 
Materials and Methods 
Cell lines 
293T cells, COS-7 cells, and HeLa cells were maintained at 37°C in a 5% CO2 
incubator in Dulbecco’s Modified Eagle’s Medium (Sigma, St. Louis, MO) 
supplemented with 10% fetal calf serum (FCS) and penicillin/streptomycin. 
 
Plasmids 
Plasmids expressing the intact M-PMV genome of wild-type (WT) or d3PY mutant, 
pSHRM15 or pd3PY, have been described previously (7, 22). To generate the 
expression plasmid for M-PMV mutants, pdPSAP, with deletion of the PSAP sequence 
within pp24/16, pAADL, pYAAL, and pYADA, with substitution of the YADL 
sequence with alanine within the p10 matrix were introduced into the wild-type M-PMV 
expression vector pSHRM15 by site-directed mutagenesis using a QuickChange 
Site-directed Mutagenesis Kit (Stratagene, La Jolla, CA).  
 
Detection of viral proteins in cell lysates and virions 
293T, COS-7, and HeLa cells were transfected with pSHRM15, pd3PY, pdPSAP, 
pAADL, pYAAL, or pYADA (1 or 2 µg) using TranslT®-LT1 (Mirus Bio Corp., 
Madison, WI). For HeLa cells, to establish lines stably expressing WT or mutant 
M-PMV, cells were incubated in the presence of hygromycin B (life technologies, 
Carlsbad, California). At 48 hours after spreading for HeLa cells and at 48 hours 
post-transfection for 293T and COS-7 cells, the culture supernatants were separated 
from cell debris by centrifugation (14200 × g; 3 min at 4°C) and which virions were 
pelleted through a 16.5% sucrose cushion by ultracentrifugation (348000 × g; 45 min at 
4°C). Pelleted virions were resuspended with PBS (–). whereas cells were lysed with 
lysis A buffer (7). Cell lysates and virions were separated by SDS-PAGE (12% and 
15%) and then transferred onto nitrocellulose membranes (GE Healthcare, Piscataway, 
NJ). The blots were probed with anti-M-PMV Gag antibody and horseradish 
peroxidase-labeled secondary antibodies, and then detected using ECL prime (GE 
Healthcare) according to the manufacturer’s instructions. Bands were visualized using 
an image analyzer (LAS-3000; GE Healthcare). 
 
Production of anti-M-PMV Gag antibody 
M-PMV Gag precursor, Pr78, was expressed in Escherichia coli BL21 (DE3) as a 
GST fusion protein (from pGEX6P-2; GE Healthcare), and purified from the bacterial 
extracts according to the manufacturer’s instructions. Because the GST fusion proteins 
attached to the glutathione-Sepharose 4B beads were digested with PreScission protease 
(GE Healthcare), the purified Gag protein did not contain GST. The purified Gag 
protein was used to immunize rabbits. 
Detection of intracytoplasmic procapsid assembly 
To analyze procapsid formation in mutant-expressing cells, the cells were washed 
with ice-cold PBS and lysed with Triton buffer (0.5% Triton X-100, 0.25 M sucrose, 1 
mM EDTA, 0.14 M NaCl, 10 mM Tris-HCL, pH7.5) for 1 hour at room temperature. 
The cell lysates were clarified of cell debris by centrifugation (14000 × g; 2 min). The 
supernatants were fractionated into free and capsid-associated Gag polyproteins by 
ultracentrifugation (48500 × g; 30 min at 4°C) through a 30% sucrose cushion. Gag 
polyproteins in supernatant and pellet fractions were analyzed by SDS-PAGE and 
Western blotting assay using anti-M-PMV Gag antibody. 
 
Immunofluorescence microscopy 
293T and COS-7 cells were spread onto Millicell® EZ SLIDES (Merck Millipore, 
Darmstadt, Germany). After 12-hour incubation, cells were transfected with pSHRM15, 
pd3PY, pdPSAP, pAADL, pYAAL, or pYADA using TranslT-LT1. At 48 hours after 
transfection, cells were washed and then fixed with 4% paraformaldehyde for 15 
minutes at room temperature. HeLa cell lines stably expressing WT or mutant M-PMV, 
were incubated onto Millicell® EZ SLIDES for 48 hours and then fixed with 4% 
paraformaldehyde for 15 minutes at room temperature. After fixation, cells were 
permeabilized with 0.1% Triton X-100 for 10 minutes and treated with blocking buffer 
(2.5% FCS and 0.2% Tween-20 in PBS) for 20 minutes. After blocking, the cells were 
incubated with anti-M-PMV Gag antibody for 1 hour, after which plasma membranes 
were incubated with Cholera Toxin Subunit B (recombinant), Alexa Fluor® 
594Conjugates (Molecular Probes Eugene, OR) for 2 hours and then FITC-conjugated 
Goat F(ab')2 anti-Rabbit IgG–H&L polyclonal secondary antibody (Abcam, Cambridge, 
UK) was also used for detection. Primary and secondary antibodies were diluted in 
blocking buffer. Fluorescence was visualized with a confocal laser scanning microscopy 
LSM710/780 (Carl Zeiss, Oberkochen, Germany). 
Results 
Roles of putative three L-domains of M-PMV Gag  
To examine the roles of the three putative L-domains of M-PMV Gag, the YxxL 
sequence within the p10MA region and the PPPY and PSAP sequences within the 
pp24/16 region, mutant M-PMV infectious clones expressing Gag with mutations in 
these L-domains were generated (Fig. 1). The mutants with deletion of the PPPY or 
PSAP sequence within pp24/pp16 were designated as d3PY and dPSAP, respectively. 
AADL, YAAL, and YADA are mutants with substitution of each amino acid within the 
YADL sequence to alanine. These plasmids expressing the L-domain mutants were 
introduced into three different cell lines: 293T, COS-7, and HeLa cells. At 48 hours 
transfection, Gag expression in 293T and COS-7cells and virion production were 
analyzed by Western blotting. HeLa cells, cell lines stably expressing WT or mutant 
M-PMV were incubated on 6-well plates for 48 hours followed by analysis of Gag 
expression in cells and virion production by Western blotting. 
The expression of Gag precursor (Pr78Gag) was observed in 293T, COS-7, and HeLa 
cells expressing either WT or mutants genomes (Fig. 2). WT and dPSAP virion 
production were also observed in 293T, COS-7, and HeLa cells; HeLa cells showed 
much less dPSAP virion production than WT (Fig. 2). d3PY and YADA were 
completely deficient in virion production in all three cell lines. Small amounts of AADL 
mutant virions were produced from 293T cells, but not from COS-7 or HeLa cells. 
Virion production levels of YAAL was similar to that of WT in HeLa cells and less than 
that of WT in 293T cells, and faint in COS-7 cells. Gag precursor expressions of AADL 
and YAAL were much higher in COS-7 cells than in WT. Nevertheless, virion 
production from COS-7 cells expressing these mutants was not observed. 
These results suggest that the PPPY motif and the tyrosine (Y) and leucine (L) 
residues within the YADL motif play essential roles in M-PMV virion production. 
Additionally, the PSAP motif was dispensable for virion production, at least in 293T 
and COS-7 cells; it was also required for efficient virion production in HeLa cells. The 
necessity of the aspartic acid (D) residue within the YADL motif for virion production 
differed between the cell lines.  
Intracytoplasmic capsid assembly of L-domain mutants 
M-PMV is a type-D retrovirus, forms a viral procapsid in the cytoplasm of the host 
cell prior to virion release. To examine whether the mutant Gag polyproteins showed 
normal intracytoplasmic procapsid assembly, cells expressing WT or mutant Gag 
polyproteins were treated with Triton buffer after which intracytoplasmic procapsids 
were pelleted through a 30% sucrose cushion by ultracentrifugation as described in the 
Methods section. After ultracentrifugation, free Gag polyproteins remained in the 
soluble fraction (S) whereas those incorporated into procapsids were recovered in the 
pellet fraction (P). The Gag polyproteins in each fraction were analyzed by SDS-PAGE 
and Western blotting. In this experiment, R55W mutant showing type-C morphogenesis, 
which assembles capsids at the plasma membrane but not in the cytoplasm, was used as 
a control (23). As shown in Fig. 3, WT and all mutant Gag polyproteins were found in 
the pellet fractions (P) of all three cell lines, whereas the Gag polyproteins of R55W 
mutant were found primarily in the soluble fraction (S), as reported previously (24). 
These results suggest that the Gag polyproteins of all L-domain mutants assemble 
intracytoplasmic procapsids normally in all three cell lines, as well as WT. 
 
Subcellular localization of the L-domain mutant Gag polyproteins 
Next, to examine whether the intracytoplasmic procapsids assembled with the 
mutant Gag polyproteins are transported normally to the plasma membrane where the 
intact virions are formed and released from cells, the subcellular localization of the 
mutant Gag polyproteins was investigated by laser confocal microscopy. In this 
experiment, we used the transport-defective A18V mutant, which accumulates 
procapsids as cytoplasmic aggregates, was used as a control (25). 
As shown in Fig. 4, WT, d3PY, dPSAP, YAAL, and R55W Gag polyproteins (Green) 
were colocalized with the plasma membrane marker (Red) in 293T cells and HeLa cells, 
whereas A18V, AADL, and YADA mutants were observed only in the cytoplasm, and 
not in the plasma membrane. WT, d3PY, dPSAP, R55W, A18V, AADL, and YADA Gag 
polyproteins also showed similar subcellular localization in COS-7 cells as in 293T cells 
and HeLa cells. On the other hand, the YAAL mutant Gag, which showed membrane 
localization in 293T cells and HeLa cells, was observed only in the cytoplasm of COS-7 
cells (Fig. 4, panel N).  
These results indicated that the YxxL motif within p10MA plays an important role in 
the intracellular transport of Gag to the plasma membrane, but not in virus budding.  
As found in virion production, the necessity of the aspartic acid (D) residue within the 
YADL sequence for membrane transport was different between cell lines. 
Discussion 
To investigate the roles of three putative L-domains of M-PMV Gag in virus 
replication, we analyzed mutants with mutations within each L-domain motif in three 
cell lines. The results are summarized in Tables 1 – 3. 
We have reported previously that the PPPY sequence within the pp24/pp16 region 
plays a critical role in M-PMV budding as an L-domain (7). Similar results have been 
reported for HTLV-1, Ebola virus, vesicular stomatitis virus (VSV), and Lassa virus, 
which contain both PPxY and PT/SAP sequences within their Gag or matrix proteins 
(26-30). Here, it was also shown that the PPxY motif plays an essential role in progeny 
virus production as a major L-domain in all three cell lines examined in this study (Fig. 
2, Tables 1 – 3).  
Gottwein et al. reported that the PSAP sequence in the pp24/16 region also functions 
as an additional L-domain in HeLaP4 cells and promotes the efficient release of 
M-PMV (21). In this study, we confirmed this observation in HeLa cells (Fig. 2, Tables 
1 – 3). However, we found that PSAP is dispensable for M-PMV production in 293T 
and COS-7 cells, suggesting that the role of the PSAP motif as an L-domain in M-PMV 
budding is cell type-dependent. The PSAP motif appears to have no or only an additive 
role in M-PMV budding in the presence of the PPxY motif. Alternative cell 
type-dependent usage of L-domains has also been reported in HTLV-1 (31). The cellular 
factors or systems that do not require the PSAP motif for virus budding should be 
present in COS-7 and 293T cells, but deficient or present at lower levels in HeLa cells. 
Viruses that possess multiple L-domains may change the L-domain usage to replicate in 
various cells. 
In this study, we identified the third L-domain-like sequence, YADL, in the p10MA 
region of M-PMV Gag and analyzed the role of this YADL sequence in M-PMV 
replication. It has been reported that the YADL motif mediates endocytosis and plays a 
critical role in glycoprotein incorporation into virions as an intracellular trafficking 
signal (32). As shown in Fig. 2 and Tables 1 – 3, the AADL and YADA mutants are 
defective in transport to the plasma membrane, but not viral capsid assembly, indicating 
that the YADL motif is required for M-PMV production as a transport signal to the 
plasma membrane, but not as an L-domain.  
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 Figure legends 
Fig. 1. Schematic representations of wild-type and L-domain mutants of M-PMV. 
M-PMV Gag has a YxxL motif within the p10MA region and PPxY and PSAP motifs 
within the pp24/pp16 region. 
 
Fig. 2. Intracellular Gag protein expression and virus production of L-domain mutants 
in 293T, COS-7 and HeLa cells. In 293T cells (A), COS-7 cells (B), and HeLa cells (C), 
intracellular Gag polyprotein Pr78 expression (upper) and Gag-derived proteins (pp24 
and p10MA) in virions produced from cells (lower) were detected by Western blotting. 
The efficiency of virus production in cells transfected with pSHRM15 (WT) was set to 
1. The data are shown as averages and standard deviations of three independent 
experiments. 
 
Fig. 3. Intracytoplasmic procapsid formation of L-domain mutants. 293T (A), COS-7 
(B), and HeLa cells (C) expressing either WT or mutant M-PMV were lysed and 
assembled intracytoplasmic procapsids pelleted by ultracentrifugation. Free Gag 
polyproteins remained in the soluble fraction (S) and those incorporated into procapsids 
were recovered in the pellet fraction (P). The Gag polyproteins in each fraction were 
analyzed by SDS-PAGE and Western blotting analysis. 
 
Fig. 4. Subcellular localization of WT or L-mutants of M-PMV Gag. In 293T, COS-7, 
or HeLa cells expressing WT or L-domain mutants of M-PMV, M-PMV Gag (Green) 
and the plasma membrane (Red) were stained as described in Materials and Methods. 
Nuclei (Blue) were stained with DAPI. The white arrowhead indicates co-localization of 
Gag and plasma membrane marker. Scale bar: 10 µm. 
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Table 1. Summary of the phenotypes of L-domain mutants of M-PMV in 293T 
cells 
 
                      





Virus release Localization 
Wild -Type 
 
+++ +++ +++ Plasma membrane 
Membrane direct transport mutant 




A18V A(18)→V +++ 
  
- Cytoplasm 
           Late domain mutants  
d3PY PPPY→deletion +++ +++ - Plasma membrane 
      
dPSAP PSAP→deletion +++ +++ +++ Plasma membrane 
           AADL Y(28)→A +++ ++ - Cytoplasm 
YAAL  D(30)→A +++ +++ ++ Plasma membrane 
YADA L(31)→A +++ +++ - Cytoplasm 
           The efficiencies of Gag precursor stability, capsid assembly and virus release in each 
mutant are indicated as follows (those in WT set to 1.0). 







Table 2. Summary of the phenotypes of L-domain mutants of M-PMV in COS-7 
cells 
 
                      





Virus release Localization 
Wild -Type 
 
+++ +++ +++ Plasma membrane 
Membrane direct transport mutant 




A18V A(18)→V +++ 
  
- Cytoplasm 
           Late domain mutants  
d3PY PPPY→deletion +++ +++ - Plasma membrane 
      
dPSAP PSAP→deletion +++ +++ +++ Plasma membrane 
           AADL Y(28)→A +++ +++ - Cytoplasm 
YAAL  D(30)→A +++ +++ - Plasma membrane 
YADA L(31)→A +++ +++ - Cytoplasm 
           The efficiencies of Gag precursor stability, capsid assembly and virus release in each 
mutant are indicated as follows (those in WT set to 1.0). 








Table 3. Summary of the phenotypes of L-domain mutants of M-PMV in HeLa 
cells 
 
                      





Virus release Localization 
Wild -Type 
 
+++ +++ +++ Plasma membrane 
Membrane direct transport mutant 
R55W R(55)→Ｗ +++ + +++ Plasma membrane 
Transport-defective mutants 
A18V A(18)→V +++ 
  
    - Cytoplasm 
           Late domain mutants 
d3PY PPPY→deletion +++ +++ - Plasma membrane 
      
dPSAP PSAP→deletion +++ +++ + Plasma membrane 
           AADL Y(28)→A +++ ++ - Cytoplasm 
YAAL  D(30)→A +++ +++ +++ Plasma membrane 
YADA L(31)→A +++ ++ - Cytoplasm 
           The efficiencies of Gag precursor stability, capsid assembly and virus release in each 
mutant are indicated as follows (those in WT set to 1.0). 
+++, > 0.8; ++, > 0.4; + > 0.2; -≦0.2; ND, not determined. 
 
 
